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The chronic stages of Bovine 
Fasciola hepatica are Dominated by 
cD4 T-cell exhaustion
Divya Sachdev1†, Kevin C. Gough1 and Robin J. Flynn2*
1 School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom, 2 Department of 
Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
Fasciola hepatica infection of ruminants leads to non-resolving chronic infection, as 
patency develops, there is switching to a TGF-β and IL-10 led response. Here, we explore 
the responses of CD4 T-cells within the major draining lymph nodes. We found minimal 
expression of Foxp3 within CD4 cells but elevated levels within the γδ (WC1+) population. 
There is a strong T-cell-intrinsic exhaustion phenotype within the hepatic lymph node 
(HLN) characterized by a lack of antigen-specific proliferation and cytokine secretion. CD4 
T-cells recovered from the HLN had high levels of PD-1 expression and low levels of IL-2 
secretion. Exogenous IL-2 partially rescued this defect; when combined with neutralization 
of IL-10 and TGF-β, full restoration of proliferation, and cytokine production was achieved. 
Moreover, there is a clear uncoupling of the mechanisms that facilitate this regulation 
with parasite-specific proliferation and cytokine secretion being governed by independent 
means. These data would suggest that there is a CD4 T-cell-intrinsic regulation in place 
early in chronic infection, potentially leading to failure in resistance to reinfection.
Keywords: Fasciola hepatica, chronic helminth infection, T-cell responses, il-10, il-2, hyporesponsive, anergy, 
Foxp3
inTrODUcTiOn
Fasciola hepatica is known to establish chronic infections in its bovine host despite the development 
of a strong type-2/CD4+ Th2 response (1). As such, animals fail to develop resistance to reinfection 
as has been demonstrated experimentally (2). Reasons underlying this have been suggested to be 
similar to those seen in other models of helminth infection. Schistosoma mansoni infection shows 
a strong increase in the number of CD4 Foxp3+ Treg cells in parallel with the Th2 response (3); 
however, a later study using live infection, as opposed to schistosome egg antigen challenge (3), 
suggested that the control of the response was not dependent on Foxp3+ T-cells but on a population 
of CD4+CD25−CTLA4+ IL-10-secreting cells (4). Further studies using Trichinella spiralis showed 
that regulation of the response against the muscle resident phase relied not only upon Foxp3+ CD4 
T-cells but also upon IL-10 from a distinct cellular source (5); echoing those findings of Helmby 
and Grencis (6) who had demonstrated that IL-10 was effective at restraining the cellular response 
directed at larvae but not intestinal adults. These findings would suggest that Foxp3 expression alone 
is not responsible for the regulatory response to tissue helminths.
Previous studies of F. hepatica in the murine model suggest that CD4 Foxp3+ T-cells expand but 
these cells make up one of two major IL-10+ T-cell populations, the second being most likely Tr1 
(CTLA4+CD25+) cells. However, while this was the case in the peritoneal cavity, no expansion of 
Foxp3+ cells were seen in the mesenteric lymph node (MLN) implicating the Tr1 population in IL-10 
production and regulatory functions (4). More recently, a murine study has definitively classified the 
CD4 T-cell population as anergic; anergy could be induced by both live infection and injection of a 
tegumental antigen preparation (FHTEG). Aldridge and O’Neill reported that PD-1, CTLA4, and 
2Sachdev et al. Anergic T-Cells during F. hepatica Infection
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1002
GRAIL (RNF128) were all upregulated in the splenic CD4 popula-
tion after antigen injection (7). The effect of FHTEG was found to 
be multimodal via both DCs and their expression of the mannose 
receptor or directly on the CD4 population itself; reflecting the 
heterogeneous nature of FHTEG. The loss of antigen-specific 
responses, both proliferation and cytokine production, could be 
restored by the addition of IL-2. In the bovine model of infection, 
we have previously shown at a peripheral level, that both TGF-β 
and IL-10 played a role in limiting IL-4 and IFN-γ production. 
The levels of IL-10 and TGF-β increased as infection progressed 
while proliferation capacity continued to diminish in the face of an 
expanding lymphocyte number (8). There appears to be multiple 
mechanisms responsible for the suppression of CD4 T-cell para-
site-specific responses that largely exclude Foxp3; should these all 
arise from a single cell population effectively targeting them via 
adjuvant to overcome their effects will be simpler than if multiple 
cell populations act in concert to suppress the CD4 response.
The mechanisms by which the adaptive immune system is 
restrained is of foremost importance for any future vaccine pros-
pects; as pre-existing anergic antigenic-specific responses could 
compromise the potential of any vaccine under field conditions. In 
particular, this is important to address within the liver environment 
where ongoing immune responses need to be controlled carefully 
to balance any potential pathology with benefits as a result of para-
site clearance. This raises several questions for the regulation of the 
F. hepatica CD4 T-cell response; herein, we examined the hepatic 
lymph node (HLN) CD4 T-cell pool for functional capacity during 
chronic patent infection with F. hepatica.
MaTerials anD MeThODs
experimental infection
Male Holstein ×  Friesian cattle at 3  months of age were used, 
animals were tested for prior exposure to F. hepatica before 
experimental infections using both serological analysis and fecal 
egg counts (FECs). Animals were infected with 250 metacer-
cariae from Ridgeway Scientific and maintained until 13 weeks 
of postinfection. Throughout the experiment, animals had 
ad  libitum access to feed and water. After, the infection period 
animals were euthanized by stunning with a captive bolt and 
exsanguination. Blood was collected weekly and, at PM, lymph 
nodes were removed and collected into sterile PBS.
Parasite-specific LFH IgG1 was determined as previously 
described using LFH (10 µg/mL) as a capture antigen (9), plates 
were probed with serially diluted serum samples. Thereafter, 
bound IgG1 was detected using mouse-anti-bovine IgG1:HRP 
(Abdserotec clone IL-A60) and TMB. Additionally, entire livers 
were removed and examined to determine the final parasite bur-
den, parasites were determined to be mature or immature on the 
basis of body shape and the development of the “shoulder” area of 
the fluke as previously described (10, 11). FECs were performed 
on 1 g of feces using the standard sedimentation technique.
ethics statement
Experiments were conducted under Home Office License PPL 
30/3239 in accordance with Animal Scientific Procedures Act 
1986 and ethical approval for the study was provided by the 
University of Nottingham SVMS and ADAS UK Animal Welfare 
and Ethics Review Committee. Animal involved in experiments 
had their suffering minimized and their welfare was as outlined 
in the guidance provided by EU Directive 2010/63/EU.
Tissue culture
Single cell suspensions were prepared from the lymph nodes 
by forcing through a 70  µm cell strainer, thereafter, red blood 
cells were lysed with ammonium chloride lysis buffer. Cells 
were washed twice in 1× PBS and resuspended at 107 cells/mL 
for cell separation. Miltenyi magnetic cell separation was used, 
as per the manufacturer’s instructions, following a primary 
incubation with the mouse anti-bovine CD4 monoclonal anti-
body (AbDserotec—clone CC30; mouse IgG1) at 1/50 dilution 
followed by incubation with secondary Miltenyi magnetic beads 
coated with anti-mouse IgG as per manufacturer’s instructions. 
Purified cells were cultured at a final density of 2 × 106/mL and 
stimulated with endotoxin-free total adult antigen extract (LFH) 
at 10  µg/mL or anti-bovine CD3 (VMRD—clone MM1A) that 
had been coated onto tissue culture plates at 1 µg/mL overnight. 
Where indicated, anti-IL-10 (AbDserotec—clone CC320) (12, 13) 
or anti-TGF (R&D Systems—polyclonal AB-100-NA) (14) were 
used at 1 µg/mL, alternatively cells were cultured in the presence 
of recombinant bovine IL-2 (Kingfisher Biotech RP0026B at the 
indicated concentrations), all cultures were in RMPI-1640 with 
10% heat-inactivated fetal calf serum (FCS), penicillin (100 U/
mL), and streptomycin (100 µg/mL).
For coculture, experiments requiring PBMCs cells were puri-
fied as before (8); PBMCs were subsequently stored in liquid 
nitrogen in 80% FCS/20% DMSO. After thawing, cells were 
washed immediately twice in complete RMPI prior to separation 
of CD4 T-cells as above. Cells were then cocultured together in 
the indicated ratios prior to analysis for either IFN-γ or prolifera-
tion using the MTT assay (Sigma-Aldrich).
Facs analysis
Single cell suspensions were stained with combinations of 
antibodies indicated below for 25 min at 4°C protected from the 
dark. Cells were acquired on a BD FACS Aria (BD Biosciences, 
San Jose, CA, USA) and gated on forward and side scatter to 
exclude damaged cells and debris. Cells were stained with com-
binations of the following; anti-bovine CD4 (Alexa Fluor® 647 
clone CC8, mouse IgG2a, AbDserotec), anti-bovine CD25 (RPE 
clone ILA111, mouse IgG AbDserotec), anti-bovine WC1 (FITC 
clone CC15, AbDserotec), anti-bovine Foxp3 (APC FJK-16s, 
rat IgG2a, eBioscience), anti-bovine CD62L (FITC clone CC32 
AbDserotec), and anti-bovine CD45RO (RPE clone IL-A116, 
AbDserotec). Appropriate isotype and unstained controls were 
captured. Data were analyzed using FlowJo version 7.6.1 analysis 
software (TreeStar, San Carlos, CA, USA).
cytokine Measurements
Supernatants were tested for the presence of cytokines using 
commercial ELISAs as follows; TGF-β (Promega-G7591), IL-4 
(Thermofisher-ESS0031), IFN-γ (MABtech-3119-1H-6), IL-5 
(LSBio LS-F6133), IL-13 (Kingfisher Biotech VS0148B), and IL-2 
FigUre 1 | Parasitological parameters and seroconversion of infected 
animals. (a) Animals were examined for pre- and postinfection parasite-specific 
IgG1 antibody titers. Using a capture ELISA endpoint, log antibody titers were 
determined for each animal at the indicated time points. (B) Fecal egg counts 
(FEC) were performed using 1 g of feces from each animal before (naïve) and 
after infection at week 13. Data are presented as eggs per gram of feces.  
(c) At postmortem, livers were removed and examined from each animal. Total 
parasite numbers were determined for each liver. Additionally, parasites were 
classified as being immature or mature for each animal also. Each data point 
presented represents and individual animal with medias for each time point 
shown on the graph; data in (a) were examined for significance using a 
Kruskal–Wallis with Dunn’s multiple comparisons where ***P < 0.001.
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(Kingfisher Biotech DIY1100B). For the detection of IL-10, IL-10 
capture antibody (AbDserotec, clone CC318) was used at 6 µg/
mL and detection IL-10 antibody (AbDserotec, biotin-conjugated 
clone CC320) was used at 2 µg/mL as previously described (15), 
with the inclusion of recombinant IL-10 as a standard curve. 
All assays were carried out as per manufacturer’s instructions 
with optical densities captured on a LT-4000 microplate reader 
(Labtech, UK) with standard curves used for quantification 
throughout.
qPcr
To measure PD-L1 and CTLA4 via qPCR, RNA was isolated from 
freshly prepared cells and converted to cDNA using the GoScript 
Reverse Transcription Kit (Promega). Primers for pdcd1 and 
ctla4 (Applied Biosystems #4351372 and #4351372) and condi-
tions used are as previously reported (16). Assays were run in 
quadruplicate on a Roche Lightcycler II, data were analyzed using 
the ΔΔCT method to determine fold expression changes relative 
to rpl19 (Applied Biosystems #4331182), which has previously 
been shown to be a suitable housekeeping gene for immunologi-
cal analysis (17).
statistical analysis
Data were plotted within GraphPad Prism (La Jolla, CA, USA), 
a P-value cutoff of 0.05 was taken as significant, and details of 
specific tests used are given in the relevant figure legends.
resUlTs
cytokine responses of cD4 T-cells at 
Draining lymph nodes of F. hepatica 
infected animals
Preinfection examination of the animals revealed neither specific 
anti-Fasciola IgG1 antibodies (Figure 1A) nor parasite eggs pre-
sent within feces (Figure 1B). However, as infection progressed, 
the development of parasite-specific IgG1 became clear at week 2 
postinfection with titers reaching a plateau by week 8 and remain-
ing at these levels until completion of the trial (Figure  1A). 
Similarly, when animals were examined for the presence of para-
site eggs in the feces, we found all animals to be egg positive, with 
a range of 2–13 eggs/g and a median count of 5 (Figure 1B). At 
postmortem, all livers were examined for the presence of infiltrat-
ing parasites in the bile ducts, gall bladder, and throughout the 
tissues; total parasite numbers and both immature and mature 
forms were counted (Figure 1C). All animals harbored parasites 
in their liver at examination; the range of total parasites recovered 
was 28–88, while all animals had greater numbers of mature 
parasites (range: 21–72) compared to immature parasites (range: 
7–28; Figure 1C).
Previous studies of the bovine cytokine response have either 
focused on the systemic response or used a transcriptomics 
approach to whole tissues. Using a well-established model of 
experimental infection, we collected the MLN and HLN from 
infected animals after the development of patency. CD4 T-cells 
were isolated by magnetic bead selection and cultured for 72 h 
in the presence of anti-CD3 or LFH; thereafter, supernatants 
FigUre 2 | Cytokine responses of the CD4 T-cell compartment within draining lymph nodes of naïve animals (left panels) or those undergoing an experimental 
chronic Fasciola hepatica infection (right panels). At 13 weeks of postinfection, CD4 T-cells were isolated from the mesenteric lymph node (MLN) (a) and hepatic 
lymph node (HLN) (B) and cultured with anti-CD3 (αCD3) or LFH. Thereafter, cytokines were measured in cell-free supernatant by ELISA. There was significant 
production of IL-10 in both compartments with both treatments, TGF-β was produced above basal levels with stimulation with αCD3 in MLN, IL-5 was produced 
with αCD3 treatment in both compartments and with LFH in HLN only. LFH stimulated the production of IL-13 in HLN. No other combinations of treatment and 
lymph node produced significant levels of cytokine. Note the different units for IL-10. Graphs represent mean ± SEM of seven animals, with technical triplicates in all 
cases. Results were tested for statistical significance using Kruskal–Wallis with Dunn’s multiple comparisons between culture condition within each cytokine, 
*P < 0.05 and **P < 0.001.
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were collected for cytokine ELISA. In both the infected MLN 
(Figure 2A, right panel) and HLN (Figure 2B, right panel), there 
was no significant IFN-γ response either to CD3 or LFH; only 
CD3 stimulation of the MLN CD4 T-cells produced some detect-
able cytokine. This is in contrast to the findings in naïve tissues, 
where T-cells from both the MLN and HLN produced significant 
IFN-γ after anti-CD3, but not LFH stimulation (Figures 2A,B, 
left panels).
Of the type-2 cytokines examined, IL-5 was the most abundant 
at this point with CD3 stimulation but not LFH in the MLN and 
both CD3 and LFH stimulation within the HLN. In contrast, the 
naïve tissues produced IL-5 in response to anti-CD3 but not LFH; 
while IL-13 was non-detectable in naïve HLN T-cells low but vari-
able levels were present in naïve MLN T-cells (Figures 2A,B, left 
panels). IL-13 was not significantly elevated except in response to 
LFH stimulation in the HLN. Indeed, only IL-10 and TGF-β were 
readily detectable in both the MLN and HLN. IL-10 was signifi-
cantly upregulated within both the MLN and HLN in response to 
both CD3 and LFH, and for these responses in the HLN parasite 
specific IL-10 was more readily produced in comparison to CD3. 
TGF-β was spontaneously produced in PBS cultures in levels 
comparable to those produced by LFH. CD3-induced TGF-β was 
significantly raised, in comparison to both PBS and LFH, within 
the MLN but not the HLN (Figure 2B). IL-4 was not detectable 
in response to either CD3 or LFH at either site (data not shown). 
Overall, this would suggest that, even in the presence of a current 
infection, the draining HLN presents a strong immunoregulatory 
pattern with minimal type-2 cytokines.
cD4 T-cells from infected animals are 
activated but Do not express Foxp3
We next examined CD4 T-cells from the HLN of infected ani-
mals, overall, there was a significant increase in the total number 
of cells from infected animals (95.2 ± 26.5 × 106 cells; P < 0.05) 
compared with naïve controls (52.9  ±  20.4  ×  106  cells). The 
percentage of CD4 cells expressing CD25, as a marker of activa-
tion was 90 vs 30% within the controls (Figure 3A, left panel), 
in parallel, we saw a decrease in the percentage of naïve CD62L+ 
CD4 T-cells, an average of 44% in controls vs 6% from infected 
animals (Figure 3A, right panel).
To determine if the CD4 pool in the lymph node of infected 
animals was committed to a memory phenotype, we examined 
the CD4+CD62L+ subpopulation for CD45RO expression. There 
was no difference in CD45RO expression between infected and 
FigUre 3 | Activation, memory, and regulatory characteristics of the CD4 T-cell pool from infected lymph nodes. Single cell suspensions from the hepatic lymph 
node of week 13 Fasciola hepatica-infected animals (squares) or naïve controls (circles) were stained for CD4, CD25, CD62L, WC1, CD45RO, or intracellularly for 
Foxp3. (a) Shows an increase in the percentage of CD4+CD25+ cells, left, and a concomitant decrease in CD4+CD62L+ double-positive cells, right, indicating the 
presence of an activated CD4 population. (B) Staining for central memory T-cells (left) and effector memory T-cells (right) revealed that there was no significant 
change in the proportion of either of these populations although a noted wide variation was present in both naïve and infected animals. (c) Expression of the 
regulatory marker, Foxp3, was not changed in the CD4+CD25+ population when compared in naive and infected animals (left graph), but was found to be 
significantly upregulated in the γδ (WC1+) population between the two groups (right graph). Each point represents an individual animal. Significant differences 
between populations are indicated on the graphs determined using a Mann–Whitney U-test; **P < 0.01, ***P < 0.001.
5
Sachdev et al. Anergic T-Cells during F. hepatica Infection
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1002
naïve animals (Figure 3B, left panel), 5.4 ± 1.8 and 4 ± 1% of 
the CD4+CD62L+ cells, respectively, suggesting no change in 
the commitment of T-cells to the central memory phenotype. 
Similarly, gating on the CD62L− pool demonstrated that 3.2 ± 1% 
of naïve CD4 T-cells were also CD45RO+ while the correspond-
ing population in infected animals was 1.7 ± 0.5%; demonstrating 
the lack of an memory cell expansion (Figure 3B, right panel). We 
stained the CD4+CD25+ T-cell population for Foxp3, we found 
FigUre 4 | Failure to produce IL-2 and markers of anergy are coincident with non-responsive CD4 T-cells. (a) CD4 T-cells were isolated from the hepatic lymph 
node (HLN) of naïve or infected animals and cultured with α-CD3, LFH, or PBS (nil) for 72 h. Supernatants were recovered at every 24 h and tested for IL-2. There is 
a clear failure of CD4 T-cells from the HLNs of infected animals to secrete IL-2. However, naïve CD4 T-cells readily secrete IL-2 over time with a near linear 
accumulation of cytokine. (B) mRNA from CD4 T-cells was isolated, cDNA prepared, and qPCR carried out. There is a clear increase in pdcd1 expression from 
week 2 onward when compared to naïve animals. Ctla4 expression is significantly upregulated at week 13 but not week 2. (c) The effect of exogenous IL-2, or 
neutralizing IL-10 or TGF-β antibody on the expression of IFN-γ (left) and IL-13 (right) in infected CD4 T-cells from HLN was examined. There was a clear impact of 
IL-2 on IFN-γ, and IL-13 production was restored in the presence of all three treatments but to varying degrees. Ctrl represents cells treated with isotype Ab only at 
equal concentrations to neutralizing Ab. (D) CD4 T-cell proliferative responses in the HLN were assessed using the MTT dye assay after stimulation in the presence 
of treatments as in (c). LFH and α-CD3 responsiveness was restored in the presence of α-IL-10 when compared within stimulation to non-treated controls. Bars 
represent the mean of seven animals ±SEM. Significant differences were determined using Friedman test with a post hoc comparison using a Wilcoxon ranked-sign 
test (a,c,D) and Kruskal–Wallis with Dunn’s multiple comparisons (B) where *P < 0.05, **P < 0.01, ***P < 0.0001.
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only 5.8 ±  1.2% of infected animals, and 5.1 ±  0.9% of naïve 
animals, harbored traditional Foxp3 Tregs (Figure 3C, left panel). 
Indeed, we found that almost 50% (±6%) of γδ (WC1+) T-cells 
were Foxp3+ in infected animals compared with approximately 
half that proportion in naïve animals (Figure 3C, right panel). 
Thus, it would appear that the lack of proliferation and cytokine 
production in infected CD4 T-cells is not due to the presence of 
Foxp3+ CD4 T-cells.
hln cD4 T-cells appear anergic
IL-2 is a limiting factor in the responsiveness of lymphocytes, 
to determine if IL-2 played a role in the observed pattern of 
responses, we repeated the above CD4+ T-cell isolation and cul-
ture in the presence of LFH or α-CD3 stimulation. Cultures were 
sampled over a 72 h period, and Figure 4A shows that neither 
CD3 nor LFH drive IL-2 secretion but that naïve animals respond 
to CD3 stimulation with a steady accumulation of IL-2. Next, we 
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conducted qPCR to determine if markers of anergy, ctla4, and 
pdcd1 were upregulated. Both ctla4 and pdcd1 are upregulated 
in CD4 T-cells derived from animals 13 weeks of postinfection 
compared to those sampled at 2 weeks of postinfection or naïve 
controls (Figure 4B).
To test if the anergy could be reversed we repeated the above 
in the presence of IL-2, α-IL-10 (clone CC320), or α-TGF-β 
(AB-100-NA). While IFN-γ secretion was restored in response to 
LFH and CD3 with exogenous IL-2, neither α-IL-10 nor α-TGF-β 
had a significant effect on IFN-γ (Figure  4C). Conversely, IL-13 
production was restored, compared to controls, in the presence of all 
three treatments during LFH and CD3 stimulation. Here, a graded 
effect was evident with an increasing capacity of IL-2, α-IL-10, and 
α-TGF-β treatments in restoring IL-13 production (Figure  4C). 
To determine if the mechanisms controlling cytokine production 
and proliferation were linked, we examined antigen-specific pro-
liferation, by MTT assay, in the presence of the IL-2, α-IL-10, and 
α-TGF-β (Figure 4D). There was a high degree of variation in the 
responses of animals to these treatments. α-IL-10 treatment suc-
ceeded in significantly restoring the capacity of cells to respond to 
CD3 stimulation; while IL-2 or α-TGF-β had some effect this was 
not significant. Similarly, when stimulated with LFH, there was a 
small, but significant increase, in proliferation with α-IL-10 while 
neither IL-2 nor α-TGF-β had any effect on proliferation.
anergic T-cells suppress autologous 
antigen-specific responses
The presence of these anergic T-cells may impact upon host 
responses to reinfection, or upon future vaccination. To test if 
the anergic T-cells could impact on normally responsive T-cells, 
we isolated CD4 T-cells from circulation at week 2 postinfection, 
when F. hepatica-infected animals are normally responsive, and 
cocultured these with anergic cells in the presence of LFH. While 
week 2 CD4 T-cells could respond normally, in the presence of 
week 13 cells, this response was abrogated (Figure 5A).
Addition of α-IL-10 resulted in an enhanced response in week 
2 cells in response to LFH, suggesting that there was inhibition 
of low-level paracrine IL-10, and an increase in the week 13 only 
cells LFH-specific response (Figure 5B), consistent with our find-
ings above. When α-IL-10 was added to the coculture, there was 
a reversal of the inhibitory effect of week 13 CD4 T-cells, and the 
IL-10 they produce, on week 2 CD T-cells. Neutralization of IL-10 
in the cocultures of these cells resulted in a threefold increase in 
proliferation. Figure 5B demonstrating that pre-existing anergic 
T-cell can be a major contributor of IL-10, altering the response 
of freshly responding non-anergic T-cells. This same trend is 
visible in terms of IL-2 production and utilization. Addition of 
exogenous IL-2 in the same system had effects on week 2 only 
CD4 cells while no effect was apparent on week 13 CD4 T-cells. 
Figure  5B in our coculture system, the effect of IL-2 addition 
was weaker compared with IL-10 neutralization as a small but 
not significant effect was seen on LFH-specific proliferation 
(Figure 5C); suggesting that proliferative hyporesponsiveness in 
this setting is mediated by IL-10. To test if the dissociation seen 
in the actions of IL-2 and IL-10 extended to cytokine production, 
we examined the secretion of IFN-γ. Figure 5C clearly shows that 
IL-2 has a more profound effect on IFN-γ secretion in cocultured 
week 2 and week 13 cells when compared with α-IL-10 treatment; 
demonstrating that the cell-intrinsic effects we found in chroni-
cally infected animals can be influential on normally responsive 
week 2 cells.
DiscUssiOn
We confirm a consistent pattern in chronic fascioliasis whereby 
Th2 cytokine responses are diminished by week 13 postinfection 
despite parasites residing in the liver. Broadly, this aligns with 
systemic PBMC responses at comparable stages of disease but 
diverges as there is an uncoupling of the regulatory mechanisms 
controlling Th2 and Th1 cytokines and cellular proliferation as 
they have been previously described (8, 18). Indeed, it would sug-
gest that there are Th1 and Th2 intrinsic mechanisms controlling 
cytokine production on a per cell basis; supported by our finding 
that the CD4 compartment does not demonstrate expansion of a 
Foxp3 population. This aligns with findings from other models of 
F. hepatica and other veterinary parasite models. Escamilla et al. 
(19) have shown in goats and sheep that there is no expansion of 
CD4+Foxp3+ cells by 9 days of infection but, by 15–19 weeks of 
postinfection, an infiltrate of these cells surrounds the enlarged 
bile ducts of livers in sheep and goats. Interestingly, when the 
HLN from the same study was examined, there was little evidence 
of expansion of the CD4 Foxp3 population with no significant 
changes in sheep with only goats showing a ~6% increase 
over baseline during the acute infection stages localized to the 
cortex. The tendency for sheep and goats to harbor expanded 
CD4+Foxp3+ cells agrees with previous studies demonstrating that 
Psoroptes ovis causes an average of a 7% increase in recruitment 
of CD4+Foxp3+ cells to the skin (20). Teladorsagia circumscintia 
studies have demonstrated an expansion in the overall Foxp3 
population in the intestine of sheep, but not specifically within 
the CD4 population (21). Prior studies demonstrated that the 
γδ (WC1) T-cell population maybe the major bovine regulatory 
population (22, 23). Recently, it has been shown that these cells can 
suppress both antigen-specific and non-specific responses within 
the context of foot-mouth-disease vaccination [23]. The effects of 
WC1+ γδ T-cells was shown to be dependent on IL-10 and TGF-β 
during these studies but independent of Foxp3; however, we did 
not characterize the effects of the WC1+ FoxP3+ population in 
this study. A definitive study of the function of Foxp3, in either 
CD4 or γδ T-cells, to demonstrate their specific actions within 
veterinary infectious disease remains to be completed. Tools are 
emerging that will allow an in vivo approach to the manipulation 
of CD4+Foxp3+ in some veterinary species already (24).
Previous studies of murine F. hepatica infection have shown 
similar effects to those demonstrated here. Aldridge and O’Neill 
(7) demonstrated a strong increase in markers of anergy, CTLA-4, 
and PD-1, within splenic CD4 T-cells; while little to no change 
was noted in the expression of FoxP3. Walsh et al. (25) studied 
the MLN and showed that there was no apparent role for Foxp3+ 
cells in the control of F. hepatica-specific responses. Our findings 
are more in keeping with these two latter studies than those using 
sheep or goats. We have demonstrated that an activated but aner-
gic CD4 T-cell population controls the expression of IFN-γ and 
IL-13 by the production of IL-10, TGF-β, and to a lesser extent 
8Sachdev et al. Anergic T-Cells during F. hepatica Infection
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1002
FigUre 5 | Continued
FigUre 5 | Continued  
Anergic CD4 T-cells are suppressive toward autologous responsive counterparts. CD4 T-cells taken from animals’ 2 weeks of postinfection were cocultured with 
autologous CD4 T-cells isolated from the hepatic lymph node at postmortem. (a) Proliferation in response to LFH is still detectable in week 2 CD4 T-cells, as per 
previous findings; however, when anergic week 13 CD4 cells are added at a ratio of five cells per 1 week 2 responder cells, we see a strong suppression of proliferation. 
(B) A similar coculture was established and the effects of α-IL-10 (left graph) and exogenous IL-2 (right graph) was determined. In the presence of α-IL-10, there was 
significant reversal of the negative effects of anergic CD4 cells on their responsive counterparts; however, there was no positive effect of exogenous IL-2. (c) IFN-γ levels 
in LFH-stimulated cells untreated (isotype control) or treated with IL-2 and α-IL-10 were determined in the coculture system. In the presence of week 13 anergic CD4 
cells, the IFN-γ response, from responsive week 2 cells, was suppressed while IL-2, but not α-IL-10 treatment, could abrogate the effect of week 13 CD4 T-cells on the 
responsive population. Bars represent the mean of seven animals’ ±SEM. Data in (a) and (B,c) were tested by Kruskal–Wallis with Dunn’s multiple comparisons and 
Friedman test with a post hoc comparison using a Wilcoxon ranked-sign test, respectively. ND, not detected; NS, not significant, *P < 0.05 and **P < 0.01.
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through the control of IL-2 activity; these same mechanisms of 
suppression were active in terms of cellular proliferation at the 
site of final parasite residence where there is a constant source 
of antigen. One of the key triggers for induction of anergy is a 
source of antigen in the absence of costimulation or the presence 
of ligands such as CTLA-4 (26).
Establishment of this phenotype within the HLN is problem-
atic and may explain the failure of animals to develop resistance 
to reinfection. We demonstrated that anergic HLN T-cells can 
suppress autologous T-cells recovered from animals during 
the responsive period. In coculture, the addition of week 13 
T-cells clearly and negatively impacted both proliferation and 
IFN-γ release. Anergic T-cells, which persist and overlap with a 
new incoming wave of parasites have the potential to skew the 
response of responsive T-cells via IL-10 production and altered 
IL-2 utilization. The uncoupling of the cytokine and proliferation 
control mechanisms is a novel finding given our previous findings 
(8); however, given that our study here is focused on lymphoid 
tissue sites and not circulating PBMCs, this is not unsurprising as 
secreting anti-inflammatory mediators is more likely effective in a 
systemic setting compared with controlling cytokine production/
utilization at a single cell level. Recent studies have identified a 
PD-L1-expressing CD4 T-cell population as also being capable of 
suppressing IFN-γ in viral infection and blocking PD-L1 in vivo 
resulted in reductions in viral load (27). However, this was at a 
systemic level and our study here identifies a lymph node residing 
CD4 pool that differs to previous systemic circulating pools in 
terms of regulating mechanisms. Additionally, the uncoupling of 
the cytokine and proliferating control mechanisms would suggest 
that lymphoid tissue sites may influence the types of regulatory 
cells (or their mechanism) that arise differently to those that 
circulate or form in circulation.
Studies of murine schistosomiasis demonstrated that resistance 
to reinfection after a drug-abbreviated infection was improved 
in the context of anti-IL-10 treatment (28). Blockade of IL-10 
resulted in a global increase in the antigen-specific Th1/Th2/Th17 
responses, an attractive proposition given the prevailing thoughts 
that ruminants are protected from F. hepatica only through a 
combined Th1/Th2 response (29). While in human schistosomia-
sis, there was significant effect of increases in posttreatment Th2/
Th17 cytokine responses and protection against reinfection (30). 
Whether these effects can be extended to fascioliasis remains to 
be examined. Moreover, to fully appreciate the role of anergy in 
the response to fascioliasis, we must consider all findings in a 
breed-specific context and the influence of MHC haplotype will 
guide the development of anergy given its reliance on antigen 
exposure and the variation within MHC complexes that has long 
been recognized in different cattle breeds (31). However, our data 
here were obtained from Holstein–Friesian cattle, which are the 
most common breed within the UK in terms of dairy production 
(32) and so are highly representative of the dairy population.
In conclusion, we have shown the presence of an antigen-spe-
cific CD4 T-cell population, which appears to be hyporesponsive 
from the initial stages of chronic infection. These cells upregulate 
CTLA-4 and PD-1, but not Foxp3, and are both suppressive in a 
cell-intrinsic manner and in the context of autologous-responsive 
cells. This is mediated by IL-10 secretion and control of IL-2 
production both of which can be reversed ex vivo to restore both 
cytokine production and proliferation. Importantly, these mecha-
nisms are uncoupled in that IL-2 and IL-10 have distinct actions, 
which appear not to overlap. It remains to be demonstrated how 
long these cells persist during infection and posttreatment in the 
context of Fascioliasis, and whether they have a functional role 
in mediating the lack of resistance to reinfection despite repeated 
drug-abbreviated infections.
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